Last updated:
August 07, 2011
* Perinatal data are the Perinatal Data Page
** Pediatric data are in
the Pediatric Data Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
-
A WEEK-IN-REVIEW FEATURED
REPORT
POSTER
Toxicity associated with the decrease of stavudine dosage from 40mg to 30mg in
first-line antiretroviral therapy
M. Pujades-Rodriguez, E. Dantony, L. Pinoges, et al
Poster
Abstract
- POSTER
Reason for changing first line antiretroviral
treatment before and after the implementation of the 2006
WHO guidelines
B. Castelnuovo, A. Kiragga, J. Ssempa, Y. Manabe
Poster
Abstract
-
POSTER
Improvement of lipodystrophy in children after substitution of stavudine with
zidovudine in NNRTI-based antiretroviral
therapy
L. Aurpibul, T. Puthanakit, S. Taejaroenkul, et al
Poster
Abstract
-
Rapid implementation of
2010 World Health Organization (WHO) recommendation for phasing out use of
Stavudine-based highly active antiretroviral therapy (HAART) for adult
HIV-infected patients in Maputo, Mozambique
S. Kelbert, M. Machado Cavalca Vieira, M.B. Pedro Matsinhe
Abstract
-
Treatment-modifying
toxicity and mortality among HIV-positive patients in Botswana
M. Farahani, H. Bussmann, C.W. Wester, et al
Abstract
-
Sustainability of
stavudine-based ART: nine out of ten replace stavudine by six years of treatment
in Cambodia
C. Kimcheng, V. Phan, S. Thai, et al
Abstract
-
Evaluating different
strategies for transitioning patients from stavudine to tenofovir in
resource-constrained settings
P. Grant, A. Talbot, E. Bendavid, et al
Abstract
|
ZDV/3TC vs d4T/3TC Outcomes among HIV-1-infected
Adults Receiving First-line Combination ART
in Botswana: Results from a Clinical Trial
W Wester, M Blevins, H Bussmann, et al
PDF Poster
Abstract
Genome-wide
Changes in Subcutaneous Adipose Tissue Gene Expression in HIV-uninfected Adults
after
2 Weeks of
ZDV or d4T with 3TC
C
Satchell, P Doolan, J Mehta, et al
Abstract
NVP and
3TC-resistant HIV-1 Detected in Antiretroviral-naïve Kenyans Initiating
NNRTI-based ART
S Dross, M Chung, J Kiarie, et al
Abstract
XVIII International AIDS Conference
|
|
| |
Eight out of ten adults on
stavudine-based antiretroviral treatment develop treatment-limiting
lipodystrophy by six years of treatment in Cambodia
J. van Griensven, V. Phan, S. Thai, et al
PDF Poster
Abstract
POSTER
Weight loss after the first year of stavudine-containing antiretroviral therapy
and its key
determinants at primary health care level in Kigali, Rwanda
J. van Griensven1, R. Zachariah, R. Colebunders, T. Reid
PDF Poster
Abstract
POSTER
Realities of reduction of stavudine use by HIV caregivers in resource limited
settings
O. Adenusi, O. Adebiyi, A. Etsetowaghan, et al
PDF Poster
Abstract
Effects of a reduced
dose of stavudine (d4T) on the incidence and severity of peripheral
neuropathy in PLHIV in South Africa
M. Pahuja, M.J. Glesby, A. Grobler, et al
Abstract
|
-
POSTER
Stavudine toxicity
in women is the main reason for treatment change in a 3 year prospective cohort
of adult patients started on first line antiretroviral treatment (ART) in
Uganda
B. Castelnuovo, A. Kiragga, M. Kamya, et al
PDF Poster
Abstract
-
Incidence of
peripheral neuropathy among patients receiving HAART regimens containing
stavudine
vs. zidovudine in Kenya
J. Njoroge, W. Reidy, G. John-Stewart.
et al
Abstract
-
Toxicity to fixed
dose stavudine, lamivudine and nevirapine in Uganda is very high but not
associated with increased virologic failure
F.C. Semitala, A. Kasirye-Kiragga, B. Castelnuovo, et al
Abstract
-
Long term
virological and immunological outcomes after stavudine-related lactic acidosis
in rural
KwaZulu-Natal
C. Houlihan, P.C. Mutevedz, R. Lessells, et al
Abstract
-
CONFERENCE POSTER
A Novel Chewable Pediatric Fixed-dose Combination of Stavudine, Lamivudine,
Nevirapine: Pharmacokinetics and
Safety in HIV-infected Thai Children
N Vanprapar, T Cressey,
E Capparelli, et al
PDF Poster
Abstract
-
CONFERENCE POSTER
Steady-state Bioequivalence of
Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine
in HIV-infected Ugandan Adults
J Byakika-Tusiime, L
Chinn, C Obua, et al
PDF Poster
Abstract
-
Predicting
Neuropathy Risk before Stavudine Prescription: An Algorithm for Minimizing
Neurotoxicity in
Resource-limited Settings
C Cherry J Affandi, E
Yunihastuti
Abstract
|
XVII International AIDS Conference
|
-
Weight evolution in patients after stavudine substitution for lipoatrophy in
Rwanda: comparison of zidovudine with tenofovir/abacavir
J. van Griensven, F. Rasschaert, E.F. Atté
POSTER -
Changes in Body Composition
Attributable to Lamivudine, Stavudine, Zidovudine, and Abacavir in HIV-infected
Persons Initiating ART
J Shlay, S Sharma, G Bartsch,, et al
PDF Poster
Abstract
-
Outcome
of Stavudine-induced Peripheral Neuropathy in HIV-infected Individuals in Rural
Uganda
G Mwima, D Moore, W Were, et
al
-
POSTER
Nevirapine Pharmacokinetics in Thai
Children Receiving either an Adult or Pediatric Fixed-dose
Combination of Stavudine, Lamivudine, and Nevirapine
K Chokephaibulkit, T Cressey, W Prasitsuebsai, et al
PDF Poster
Abstract
-
Adverse Effect of ddI, ddC and d4T as a Component of HAART on
Cognitive Function
during HIV Infection
I Husstedt, B
Hudelmeier, U Oelker-Gruneberg, et al
Abstract
4th
International AIDS Society (IAS) Conference on HIV
Pathogenesis, Treatment and Prevention |
-
Viral load decay in advanced naïve patients treated with
enfuvirtide based HAART: a pilot
randomised controlled study
Abstract
-
A randomised study to evaluate injection site reactions (ISR)
using three different mechanisms
for delivery of enfuvirtide (ENF): a 27-gauge needle, a 31-gauge
needle and a needle-free device
Boyd M, Truman M, Hales G, et al
Abstract
-
Recovery of anti-JCV specific T cell responses and better survival
on intensified antiretroviral
therapy in HIV-1 infected patients with progressive multifocal
leukoencephalopathy: the ANRS 125
trial
Gasnault J, Hendel Chavez H, Darasteanu I, et al
Abstract
-
The prevalence of resistant mutations to enfuvirtide in
antiretroviral naive HIV-1 infected
patients
Chew CB, Shah M, Wang B, Shaw CO, et al
Abstract
-
French observatory of HIV-1 infected patients experiencing
virological failure while receiving enfuvirtide
salvage antiretroviral therapy containing regimen
Descamps D, Assoumou L, Masquelier B, et al
Abstract
-
Effects
of a NRTI, Stavudine, on Insulin Sensitivity and Mitochondrial Function in
Muscle of Healthy Adults
A Fleischman, S Johnsen, D
Systrom, et al
Abstract
-
Tenofovir Resistance among HIV-infected Patients Failing a Fixed-dose
Combination of Stavudine +
Lamivudine + Nevirapine in a Resource-limited Setting
S Sungkanuparph, W Manosuthi,
S Kiertiburanakul, et al
Abstract
-
Development of Drug Resistance in a Sub-Saharan Cohort of HIV 1-infected
Adult Patients Receiving
Fixed-dose Combination of Stavudine + Lamivudine + Nevirapine as Standard
First-line Regimen
AG Marcelin, B Jarrousse, M
Ba, et al
Abstract
-
POSTER
Severe Hyperlactatemia
Complicating ART with Stavudine First-line Therapy in South Africa:
Incidence,
Risk Factors, and Outcomes
M Osler, D Stead, K Rebe, et al
PDF Poster
Abstract
|
XVI
International AIDS Conference
|
Abstract
First
line standard antiretroviral therapy (stavudine+lamivudine+nevirapine), a good
or a bad option
for
non-naïve AIDS patients previously exposed to NRTI and/or NNRTI?
Carillo de Casas E., Alonso E., Boon A.
Abstract
Changes
in adipose tissue mitochondrial DNA quality and quantity - relation to HIV
disease,
lipoatrophy and exposure to stavudine
Mallon P, Sedwell R, Duarte N, et al
Abstract
A
history of stavudine (d4T) predicts high HOMA index three years after ART start
Koppel K, Lund B, Sandström E. et al
Abstract
Stavudine or didanosine use, low-level transaminitis (LLT) and hepatic steatosis
in a cohort of
HIV
mono-infected subjects
Bongiovanni M, Smith C, Bhagani S, et al
Abstract
Characteristics and outcomes of patients with symptomatic hyperlactatemia, on a
first-line
antiretroviral regimen of stavudine, lamivudine and nevirapine (D4T/3TC/NVP) in
an urban district
hospital setting in Kenya
Kimani DK., Filén F., Nderitu M., et al
Abstract
Effectiveness and safety of stavudine (d4T) + tenofovir (TDF) backbone as rescue
therapeutic
strategy for HIV-infected patients - GPT study
Pedrol E., Pascual A., Ribera E., et al
Abstract
Effects
of antiretroviral drugs: stavudine, lamivudine and Nevirapine on CD4+ count and
viral
load in
HIV-1 patients attending Jos University Teaching Hospital, Jos Plateau State,
Nigeria
Mu'azu M., Monday D., Bitrus B., et al
Abstract |
6th
IAS Conference